Sumer K. Wallace, MD close
Sumer K. Wallace, MD

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Sumer K. Wallace, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Wallace is an assistant professor in the Department of Obstetrics and Gynecology at the University of Wisconsin School of Medicine and Public Health, Madison WI. She specializes in treating patients with gynecologic cancer including ovarian, fallopian tube, primary peritoneal, endometrial, vulvar and cervical. She is a Congressional Ambassador for the Society of Gynecologic Oncology (SGO) and on the SGO Policy, Quality and Outcomes Taskforce. In addition to patient care, she is interested in healthcare delivery, healthcare policy and advocacy. Quality of life for her patients is very important and Dr. Wallace uses a team approach to care for her patients, their support team and family members.


Gynecologic Oncology

Gynecologic Cancer (Cervical, Ovarian, Uterine, Vulvar)


SwedishAmerican Regional Cancer Center
(779) 696-9400 | | Map
UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Obstetrics and Gynecology

Professional Certifications and Education

Board Certification Obstetrics & Gynecology

Gynecologic Oncology, Mayo School of Graduate Medical Education, Mayo Clinic, Rochester, MN

Residency University of Colorado Hospital, Denver, CO
Mayo Clinic, Rochester, MN
Medical School Southern Illinois University School of Medicine, Springfield, IL

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

Dr. Wallace’s research focuses on quality and outcomes, quality of life and satisfaction and cancer prevention. 

PubMed Articles
Kumar A Wallace SA Cliby WA Glaser GE Mariani A Leitao MM Frumovitz M Langstraat CL Impact of Sentinel Node Approach in Gynecologic Cancer on Training Needs. J Minim Invasive Gynecol . 2019 May - Jun;26(4):727-732
[PubMed ID: 30138740]
Wallace SK Halverson JW Jankowski CJ DeJong SR Weaver AL Weinhold MR Borah BJ Moriarty JP Cliby WA Kor DJ Higgins AA Otto HA Dowdy SC Bakkum-Gamez JN Optimizing Blood Transfusion Practices Through Bundled Intervention Implementation in Patients With Gynecologic Cancer Undergoing Laparotomy. Obstet Gynecol . 2018 May;131(5):891-898
[PubMed ID: 29630007]
Wallace S Hanson KT Dowdy SC Habermann EB Impact of surgical approach and patient factors on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey scoring in gynecologic surgery. Gynecol Oncol . 2018 Jan;148(1):28-35
[PubMed ID: 29221835]
Torres D Kumar A Wallace SK Bakkum-Gamez JN Konecny GE Weaver AL McGree ME Goode EL Cliby WA Wang C Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer. Gynecol Oncol . 2017 Dec;147(3):503-508
[PubMed ID: 28964622]
Wallace S Kumar A Mc Gree M Weaver A Mariani A Langstraat C Dowdy S Bakkum-Gamez J Cliby W Efforts at maximal cytoreduction improve survival in ovarian cancer patients, even when complete gross resection is not feasible. Gynecol Oncol . 2017 Apr;145(1):21-26
[PubMed ID: 28159407]
Wallace SK Fazzari MJ Chen H Cliby WA Chalas E Outcomes and Postoperative Complications After Hysterectomies Performed for Benign Compared With Malignant Indications. Obstet Gynecol . 2016 Sep;128(3):467-75
[PubMed ID: 27500339]
Wallace SK Lin JF Cliby WA Leiserowitz GS Tergas AI Bristow RE Refusal of Recommended Chemotherapy for Ovarian Cancer: Risk Factors and Outcomes; a National Cancer Data Base Study. J Natl Compr Canc Netw . 2016 May;14(5):539-50
[PubMed ID: 27160232]
Wallace SA Blough KL Kondapalli LA Fertility preservation in the transgender patient: expanding oncofertility care beyond cancer. Gynecol Endocrinol . 2014;30(12):868-71
[PubMed ID: 25254620]
Casey PM Gallenberg MM Kastner TM Barrette BA Chantigian PD Shuster LT MacLaughlin KL Allensworth SK Weaver AL Outcomes in women age 40 years and older with cytologically benign endometrial cells. Am J Obstet Gynecol . 2012 Nov;207(5):379.e1-6
[PubMed ID: 22964067]
Bakkum-Gamez JN Langstraat CL Martin JR Lemens MA Weaver AL Allensworth S Dowdy SC Cliby WA Gostout BS Podratz KC Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian carcinoma. Gynecol Oncol . 2012 Jun;125(3):614-20
[PubMed ID: 22370599]